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Background
Use of extracorporal circulation (cardiopulmonary
bypass) during cardiac surgery can cause a systemic
inflammatory response. This so called “post-perfusion-
syndrome” (PPS) occurs in about a quarter of patients
and results in clinical signs and symptoms of “systemic
inflammatory response syndrome” (SIRS) in 2-10% of
patients. This condition is clinically associated with mild
hyperthermia, acidosis, tachycardia and vasoplegia. It is
generally treated with cristalloid infusions and vasopres-
sors, and is mostly subsided by the next morning, at the
latest after 48h.
Malignant hyperthermia is associated with a severe
combined (respiratory and metabolic) acidosis, hyperlac-
tatemia, hypercapnia, hyperthermia, grossly elevated
serum levels of creatine kinase (CK) and acute renal
failure.
Case report
We present a 23-year old patient, who gradually devel-
oped multi-organ failure following mitral valve repair for
severe secondary mitral regurgitation due to dilated car-
diomyopathy. His past medical history included partial
hepatectomy for hepatoblastoma in childhood (1982) and
partial lung resection due to recurrent pneumothoraces
in 2002. Induction of general anesthesia was carried out
with thiopentone, sufentanil and cis-atracurium and was
maintained with isoflurane as the hypnotic agent. Follow-
ing surgery, the patient showed increased infusion
requirements and was highly vasopressor-dependent.
Due to oliguric renal failure and refractory metabolic
acidosis, continuous veno-venous hemodiafiltration was
instituted early. Increased volume and vasopressor
needs gradually decreased within the first 30 hours. In
conjunction with two episodes of body temperature
peaks of > 39°C in “non-CRRT-intervals”, the deferred
but disproportionate elevation of serum-creatinkinase
activity led to the clinical suspicion of malignant
hyperthermia (Table 1). Much later, long after hospital
discharge, MH was confirmed by in vitro testing.
Conclusions
High volume requirements and vasopressor-dependency
occur commonly following surgical mitral valve repair,
especially in patients with severely impaired left ventricu-
lar function. Differential diagnosis of hyperthermia on
the ICU includes microbial triggers of the systemic
inflammatory process, which could have been the case in
this patient, where an infection might have been sus-
pected. PPS and SIRS do not prompt any suspicion of
malignant hyperthermia. Nevertheless, rare causes of
both, hyperthermia and volume-depletion should be
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Table 1 Metabolic parameters and adrenergic drug
application during the hospital stay of the patient.
D=day; WBC=white blood count; CK=creatine kinase;
TNI=troponine I; NA=noradrenalin, VP=vasopressin;
DBX=dobutamin; ADR=adrenalin; MIL=milrinone
D0 D1 D2 D3 D4 D7
Lactate (mmol/l) 10.2 3.8 2.5 1.5 1.5 1.0
pH 7.22 7.38 7.49 7.47 7.49 7.45
WBC (G/L) 28.91 20.12 18.33 19.71 27.93 19.53
CK (U/L) 1159 1645 17926 25119 19828 12908
CK-MB (µg/L) 67.4 65.9 168.7 62.2 26.1 4.4
TNI (ng/ml) 17.50 13.50 9.03 6.59 3.34 1.20
NA (µg/min) 130 40 50 5 - -
VP (IU/h) 2 2 - - - -
DBX (µg/min) 1000 1000 1000 1000 1000 1000
ADR (µg/min) 40 30 16 20 7 -
MIL (µg/h) 4000 4000 4000 4000 4000 -
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taken into account, even if the clinical course is rather
mild in a way so that MH appears almost unlikely.
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